97 related articles for article (PubMed ID: 1651794)
1. Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation.
Hunter AE; Prentice HG; Pothecary K; Coumar A; Collis C; Upward J; Murdoch R; Gandhi L; Hamon M; Butler M
Bone Marrow Transplant; 1991 Jun; 7(6):439-41. PubMed ID: 1651794
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation.
Spitzer TR; Friedman CJ; Bushnell W; Frankel SR; Raschko J
Bone Marrow Transplant; 2000 Jul; 26(2):203-10. PubMed ID: 10918432
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
[TBL] [Abstract][Full Text] [Related]
4. Granisetron in the prevention of irradiation-induced emesis.
Prentice HG; Cunningham S; Gandhi L; Cunningham J; Collis C; Hamon MD
Bone Marrow Transplant; 1995 Mar; 15(3):445-8. PubMed ID: 7599570
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of granisetron, a 5-HT3 antagonist, in the prevention of nausea and vomiting induced by conditioning for hematopoietic stem cell transplantation].
Hirabayashi N; Goto S; Morishima Y; Sao H; Matsuyama T; Kodera Y; Yamada H; Horibe K; Yano K; Kojima H; Ogura M; Tanimoto M; Morishita Y; Yazaki M; Utsumi M; Nagata K; Kato Y; Naoe T; Saito H
Rinsho Ketsueki; 1998 Jan; 39(1):21-6. PubMed ID: 9492549
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
Chiou TJ; Tzeng WF; Wang WS; Yen CC; Fan FS; Liu JH; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
8. [BRL 43694A--a 5-hydroxytryptamine receptor blocker as an antiemetic in cytostatic therapy].
Joss R; Rohrbach D; Buser K; Pirovino M; Karde C; Brunner K
Schweiz Med Wochenschr; 1989 Jun; 119(23):831-4. PubMed ID: 2549616
[TBL] [Abstract][Full Text] [Related]
9. A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy. The Granisetron Study Group.
Smith IE
Eur J Cancer; 1990; 26 Suppl 1():S19-23. PubMed ID: 2169780
[TBL] [Abstract][Full Text] [Related]
10. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
11. Granisetron: is there a dose-response effect on nausea and vomiting?
Minami M
Cancer Chemother Pharmacol; 2003 Aug; 52(2):89-98. PubMed ID: 12783208
[TBL] [Abstract][Full Text] [Related]
12. [Ondansetron in the prevention of radiation-induced nausea and emesis in patients treated with single-fraction irradiation].
Jeremić B
Srp Arh Celok Lek; 1996; 124(5-6):131-4. PubMed ID: 9102832
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis.
Cupissol DR; Serrou B; Caubel M
Eur J Cancer; 1990; 26 Suppl 1():S23-7. PubMed ID: 2169782
[TBL] [Abstract][Full Text] [Related]
14. An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy.
Tabona MV
Eur J Cancer; 1990; 26 Suppl 1():S37-44. PubMed ID: 2169785
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis.
Belkacémi Y; Ozsahin M; Pène F; Rio B; Sutton L; Laporte JP; Touboul E; Gorin NC; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):77-82. PubMed ID: 8823261
[TBL] [Abstract][Full Text] [Related]
16. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.
Martoni A; Piana E; Strocchi E; Angelelli B; Guaraldi M; Zamagni C; Camaggi CM; Pannuti F
Anticancer Res; 1998; 18(4B):2799-803. PubMed ID: 9713464
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of granisetron in the prevention of chemotherapy-induced emesis in paediatric patients.
Lemerle J; Amaral D; Southall DP; Upward J; Murdoch RD
Eur J Cancer; 1991; 27(9):1081-3. PubMed ID: 1659848
[TBL] [Abstract][Full Text] [Related]
18. [Value of granisetron in the prevention of digestive disorders in total body irradiation].
Feuvret L; Jammet P; Campana F; Cosset JM; Fourquet A
Bull Cancer Radiother; 1994; 81(1):41-4. PubMed ID: 7893522
[TBL] [Abstract][Full Text] [Related]
19. [The use of granisetron per os in radiotherapy-induced emesis].
Krengli M; Lazzari R; Manara M
Minerva Med; 1996 Dec; 87(12):605-8. PubMed ID: 9064597
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group.
Chevallier B
Eur J Cancer; 1990; 26 Suppl 1():S33-6. PubMed ID: 2169784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
